Menu Search
Equities

Marinus Pharmaceuticals Inc

0JYL:LSE

Marinus Pharmaceuticals Inc

Actions
  • Price (USD)1.56
  • Today's Change0.038 / 2.51%
  • Shares traded142.00
  • 1 Year change-77.50%
  • Beta--
Data delayed at least 20 minutes, as of Sep 19 2024 14:37 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Marinus Pharmaceuticals Inc fell by 119.98m. Cash Flow from Financing totalled 26.63m or 85.92% of revenues. In addition the company used 118.00m for operations while cash used for investing totalled 28.61m.
Cash flow per share-2.65
Price/Cash flow per share--
Book value per share-0.8614
Tangible book value per share-0.8614
More ▼

Balance sheet in USDView more

Marinus Pharmaceuticals Inc has a Debt to Total Capital ratio of 610.18%, a higher figure than the previous year's 118.83%.
Current ratio2.28
Quick ratio2.15
Total debt/total equity--
Total debt/total capital6.10
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.